Response to Machiels et al. reconsidering the role of PMRT in low to intermediate risk breast cancer: applying results from previous standards of treatments in the current multimodal practice
1 Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands. Electronic address: n.russell@nki.nl.
2 Edinburgh Breast Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: mike.dixon@ed.ac.uk.
3 University College, Gower Street, London WC1E 6BT,UK. Electronic address: r.sainsbury@gmail.com.
4 School of Clinical Medicine, UNSW Medicine & Health, The University of New South Wales, UNSW SYDNEY, NSW 2052, Australia. Electronic address: Boon.Chua@health.nsw.gov.au.
5 Department of Pathology Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: jeremy.thomas2@btinternet.com.
6 Division of Cancer Studies and Pathology, St James's University Hospital, University of Leeds, Beckett Street, Leeds, West Yorkshire LS9 7TF,UK. Electronic address: a.m.hanby@leeds.ac.uk.
7 Institute of Genetics and Cancer, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: i.kunkler@ed.ac.uk.